Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Identification of Coating Materials – V 2.0

Posted on By

Analytical Method Development: SOP for Identification of Coating Materials – V 2.0

Standard Operating Procedure for Identification of Coating Materials in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/287/2025
Supersedes SOP/AMD/287/2022
Page No. Page 1 of 11
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To define the procedure for identifying and confirming the presence and composition of coating materials applied to pharmaceutical solid oral dosage forms using analytical techniques such

as FTIR, UV, HPLC, and thermal analysis.

2. Scope

This SOP applies to Analytical Method Development and Quality Control departments involved in the qualitative and semi-quantitative analysis of film coatings, enteric coatings, and sustained-release polymers used in tablet or capsule formulations.

3. Responsibilities

  • Analytical Scientist: Develops and executes analytical methods for coating material identification.
  • QC Analyst: Performs routine analysis and documentation of results.
  • QA Executive: Verifies compliance and ensures traceability of results for regulatory submissions.
See also  Analytical Method Development: Literature Review for Method Development - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that all analytical techniques used for coating identification are validated, reliable, and compliant with ICH and pharmacopeial guidelines.

5. Procedure

5.1 Sample Preparation

  1. Gently scrape the coating from 10 tablets or remove coating using suitable solvent (e.g., water, ethanol, or methanol).
  2. Dry and weigh the residue if needed for quantitative estimation.
  3. Dissolve or disperse the coating material in an appropriate solvent for further analysis.

5.2 FTIR Spectroscopy

  1. Prepare a KBr pellet or use ATR mode for film residues.
  2. Record spectra from 4000–400 cm-1.
  3. Compare against standard library spectra for common coating materials (e.g., HPMC, PVA, Eudragit®, ethyl cellulose).

5.3 UV-Vis Spectrophotometry

  1. Applicable for colored coatings or functional layers with UV-absorbing excipients.
  2. Measure λmax and compare absorbance with standard solutions.
See also  Analytical Method Development: Identification of Impurities in API - V 2.0

5.4 HPLC Analysis

  1. Dissolve coating in methanol or suitable mobile phase.
  2. Inject 20 µL onto a C18 column using gradient or isocratic conditions.
  3. Detect typical polymers or plasticizers (e.g., PEG, triethyl citrate) based on known retention times.

5.5 Thermal Analysis (DSC/TGA)

  • Use Differential Scanning Calorimetry (DSC) or Thermogravimetric Analysis (TGA) to assess thermal properties of film coatings.
  • Identify unique endothermic/exothermic transitions or degradation patterns indicative of specific polymers.

5.6 Data Interpretation

  • Use overlay comparison against reference materials for confirmation.
  • Report matches with confidence score (for FTIR), retention time match (for HPLC), and melting point/Tg (for DSC).

6. Abbreviations

  • FTIR: Fourier Transform Infrared Spectroscopy
  • HPLC: High Performance Liquid Chromatography
  • DSC: Differential Scanning Calorimetry
  • Tg: Glass Transition Temperature
  • QA: Quality Assurance

7. Documents

  1. Coating Identification Data Log – Annexure-1
  2. FTIR/HPLC Chromatograms – Annexure-2
  3. Thermal Profile Comparison Sheet – Annexure-3

8. References

  • USP <831>: Infrared Spectrophotometry
  • ICH Q6A: Specifications: Test Procedures and Acceptance Criteria
  • Ph. Eur. 2.2.24: Identification by Infrared Spectrophotometry

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Rekha Kulkarni Anil Chauhan Sunita Reddy
Designation Analytical Chemist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Coating Identification Data Log

Sample ID Test Performed Polymer Identified Status
CMT-287-01 FTIR HPMC Confirmed

Annexure-2: FTIR/HPLC Chromatograms

Overlay of sample spectra with reference polymer. Peak at 1045 cm-1 confirms HPMC identity.

Annexure-3: Thermal Profile Comparison Sheet

DSC curve shows endothermic transition at 170°C matching reference HPMC polymer.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Included thermal and UV analysis, clarified sample prep for coated tablets Annual Review Sunita Reddy
05/10/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: SOP for Verification of Analytical Calculations - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: When and Why Should SOPs Be Revised?
Next Post: SOPs Signed but Not Implemented Across All Shifts: A Hidden GMP Gap

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version